180 related articles for article (PubMed ID: 38512983)
1. Mice with renal-specific alterations of stem cell-associated signaling develop symptoms of chronic kidney disease but surprisingly no tumors.
Myszczyszyn A; Popp O; Kunz S; Sporbert A; Jung S; Penning LC; Fendler A; Mertins P; Birchmeier W
PLoS One; 2024; 19(3):e0282938. PubMed ID: 38512983
[TBL] [Abstract][Full Text] [Related]
2. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway.
Wang G; Zhang ZJ; Jian WG; Liu PH; Xue W; Wang TD; Meng YY; Yuan C; Li HM; Yu YP; Liu ZX; Wu Q; Zhang DM; Zhang C
Mol Cancer; 2019 Jan; 18(1):15. PubMed ID: 30670025
[TBL] [Abstract][Full Text] [Related]
3. NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/β-catenin signalling pathway in clear cell renal cell carcinoma.
Wang Q; Ding H; He Y; Li X; Cheng Y; Xu Q; Yang Y; Liao G; Meng X; Huang C; Li J
Cancer Lett; 2019 Mar; 444():9-19. PubMed ID: 30543814
[TBL] [Abstract][Full Text] [Related]
4. Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis.
Wang SS; Gu YF; Wolff N; Stefanius K; Christie A; Dey A; Hammer RE; Xie XJ; Rakheja D; Pedrosa I; Carroll T; McKay RM; Kapur P; Brugarolas J
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16538-43. PubMed ID: 25359211
[TBL] [Abstract][Full Text] [Related]
5. SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt/β-catenin signaling.
Chen L; Xie Y; Ma X; Zhang Y; Li X; Zhang F; Gao Y; Fan Y; Gu L; Wang L; Zhang X; Fu B
Mol Carcinog; 2020 Oct; 59(10):1159-1173. PubMed ID: 32794610
[TBL] [Abstract][Full Text] [Related]
6. Multilevel Regulation of β-Catenin Activity by SETD2 Suppresses the Transition from Polycystic Kidney Disease to Clear Cell Renal Cell Carcinoma.
Rao H; Li X; Liu M; Liu J; Feng W; Tang H; Xu J; Gao WQ; Li L
Cancer Res; 2021 Jul; 81(13):3554-3567. PubMed ID: 33910928
[TBL] [Abstract][Full Text] [Related]
7. miR-106b-5p promotes renal cell carcinoma aggressiveness and stem-cell-like phenotype by activating Wnt/β-catenin signalling.
Lu J; Wei JH; Feng ZH; Chen ZH; Wang YQ; Huang Y; Fang Y; Liang YP; Cen JJ; Pan YH; Liao B; Chen WF; Chen W; Luo JH
Oncotarget; 2017 Mar; 8(13):21461-21471. PubMed ID: 28423523
[TBL] [Abstract][Full Text] [Related]
8. ESM-1 Mediates Cell Progression in Clear Cell Renal Cell Carcinoma by Affecting Wnt/β-Catenin Signalling Pathway.
Liu X; Wang F; Du W; Yang X
Arch Esp Urol; 2023 Jun; 76(4):290-297. PubMed ID: 37455528
[TBL] [Abstract][Full Text] [Related]
9. A regulatory circuit of lncRNA NLGN1-AS1 and Wnt signalling controls clear cell renal cell carcinoma phenotypes through FZD4-modulated pathways.
Gao H; Chen W; Pan G; Liu H; Qian J; Tang W; Wang W; Qian S
Aging (Albany NY); 2022 Sep; 15(24):15624-15639. PubMed ID: 36170021
[TBL] [Abstract][Full Text] [Related]
10. Generation of a mouse model of Von Hippel-Lindau kidney disease leading to renal cancers by expression of a constitutively active mutant of HIF1α.
Fu L; Wang G; Shevchuk MM; Nanus DM; Gudas LJ
Cancer Res; 2011 Nov; 71(21):6848-56. PubMed ID: 21908555
[TBL] [Abstract][Full Text] [Related]
11. MCPIP1 inhibits Wnt/β-catenin signaling pathway activity and modulates epithelial-mesenchymal transition during clear cell renal cell carcinoma progression by targeting miRNAs.
Gorka J; Marona P; Kwapisz O; Waligórska A; Pospiech E; Dobrucki JW; Rys J; Jura J; Miekus K
Oncogene; 2021 Dec; 40(50):6720-6735. PubMed ID: 34657130
[TBL] [Abstract][Full Text] [Related]
12. IL6 and CCL18 Mediate Cross-talk between VHL-Deficient Kidney Cells and Macrophages during Development of Renal Cell Carcinoma.
Nguyen TN; Nguyen-Tran HH; Chen CY; Hsu T
Cancer Res; 2022 Aug; 82(15):2716-2733. PubMed ID: 35666812
[TBL] [Abstract][Full Text] [Related]
13. β-catenin links von Hippel-Lindau to aurora kinase A and loss of primary cilia in renal cell carcinoma.
Dere R; Perkins AL; Bawa-Khalfe T; Jonasch D; Walker CL
J Am Soc Nephrol; 2015 Mar; 26(3):553-64. PubMed ID: 25313256
[TBL] [Abstract][Full Text] [Related]
14. Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine.
Lobo NC; Gedye C; Apostoli AJ; Brown KR; Paterson J; Stickle N; Robinette M; Fleshner N; Hamilton RJ; Kulkarni G; Zlotta A; Evans A; Finelli A; Moffat J; Jewett MA; Ailles L
BMC Cancer; 2016 Jul; 16():485. PubMed ID: 27422173
[TBL] [Abstract][Full Text] [Related]
15. VHL-HIF-2α axis-induced SEMA6A upregulation stabilized β-catenin to drive clear cell renal cell carcinoma progression.
Ji J; Xu Y; Xie M; He X; Ren D; Qiu T; Liu W; Chen Z; Shi W; Zhang Z; Wang X; Wang W; Ma J; Qian Q; Jing A; Ma X; Qin J; Ding Y; Geng T; Yang J; Sun Z; Liu W; Liu S; Liu B
Cell Death Dis; 2023 Feb; 14(2):83. PubMed ID: 36739418
[TBL] [Abstract][Full Text] [Related]
16. Combined deletion of Vhl, Trp53 and Kif3a causes cystic and neoplastic renal lesions.
Guinot A; Lehmann H; Wild PJ; Frew IJ
J Pathol; 2016 Jul; 239(3):365-73. PubMed ID: 27126173
[TBL] [Abstract][Full Text] [Related]
17. Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer.
Bhagat TD; Zou Y; Huang S; Park J; Palmer MB; Hu C; Li W; Shenoy N; Giricz O; Choudhary G; Yu Y; Ko YA; Izquierdo MC; Park AS; Vallumsetla N; Laurence R; Lopez R; Suzuki M; Pullman J; Kaner J; Gartrell B; Hakimi AA; Greally JM; Patel B; Benhadji K; Pradhan K; Verma A; Susztak K
J Biol Chem; 2017 Jan; 292(3):837-846. PubMed ID: 27909050
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of SDHA inhibited proliferation, migration, and invasion of clear cell renal cell carcinoma cells via inactivation of the Wnt/β-catenin pathway.
Xu X; Zhang N; Gao R; Wang J; Dai Z; Bi J
J Recept Signal Transduct Res; 2022 Apr; 42(2):180-188. PubMed ID: 33602019
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
Huang JL; Liao Y; Qiu MX; Li J; An Y
Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
[TBL] [Abstract][Full Text] [Related]
20. WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.
Hsu RJ; Ho JY; Cha TL; Yu DS; Wu CL; Huang WP; Chu P; Chen YH; Chen JT; Yu CP
PLoS One; 2012; 7(10):e47649. PubMed ID: 23094073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
